SCHEMBL7999668

SCHEMBL7999668

CC1CC(=O)N(c2ccc(N)cc2)N1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 8/20 0.42
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ GFER P55789 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ ADRA2C P18825 1/20 0.38
▸ PTK2B Q14289 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ DDB1 Q16531 1/20 0.34
▸ CRBN Q96SW2 1/20 0.34
▸ CASP6 P55212 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14003557 0.79 MAPT (0.39) CYP19A1ALDH1A1KDM4EMAPTKMT2A
SCHEMBL23918368 0.77 RECQL (0.41) ALDH1A1KDM4EMAPTKMT2ARECQL
SCHEMBL30912518 0.67 ALDH1A1 (0.42) CYP19A1ALDH1A1KDM4EMAPTKMT2A
SCHEMBL30912507 0.67 ALDH1A1 (0.42) CYP19A1ALDH1A1KDM4EMAPTKMT2A
SCHEMBL25416662 0.67 ALDH1A1 (0.42) CYP19A1ALDH1A1KDM4EMAPTKMT2A
SCHEMBL13478303 0.67 L3MBTL1 (0.47) CYP19A1ALDH1A1KDM4EMAPTGAA
SCHEMBL11090155 0.66 CYP19A1 (0.50) CYP19A1
SCHEMBL10499193 0.64 CYP19A1 (0.44) CYP19A1ALDH1A1KDM4EMAPTKMT2A
SCHEMBL10556483 0.64 GAA (0.33) ALDH1A1KMT2AMEN1GAASMN1; SMN2
SCHEMBL9123388 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 — — US disclosed
Send feedback